Department of Pathology and Molecular Medicine


site header


Welcome to RauhLab, home of translational and transformative myeloid pathology and research!​ Our focus is on myelodysplastic syndromes (MDS) and myeloid innate immunity.
We strive to provide novel and more objective genomic and proteomic tests, in order to detect myeloid cancer earlier and better inform treatment.  Moreover, by understanding how cancers manipulate the innate immune environment, we hope to discover novel biomarkers and treatment targets.  Applying this knowledge, our goal is to provide more personalized diagnosis and care.​ 
  • Our brand is “QMyPath” – “Q” for Queen’s, “My” for myeloid and the patient-focused nature of our research, and “Path” for pathology and the road to personalized medicine

  • RAW 264.7 macrophage-like cells - immunofluorescence

    RAW 264.7 macrophage-like cells - immunofluorescence

  • gloved hands with pipette working over a lab bench

    Translational molecular biology at work

  • Two bench-top insturments called NanoString nCounters

    NanoString nCounter

  • primary macrophage – immunofluorescence

    Primary macrophage – immunofluorescence

  • Image of Caroline Lin standing beside her undergraduate poster

    Caroline Lin, undergraduate poster

  • photo of labl members in front of Flora Shan's undergraduate poster

    Flora Shan, undergraduate poster